A randomized controlled trial of low-dose Enoxaparin versus low-dose Edoxavan for prevention of venous thromboembolism after total hip arthroprasty in elderly or underweight or moderate renal insufficient patients.
Not Applicable
- Conditions
- osteoarthritis of the hip, osteonecrosis of the femoral head, femoral neck fracture, rheumatoid arthritis, rapidly destructive coxarthropathy, septic arthritis of the hip
- Registration Number
- JPRN-UMIN000026819
- Lead Sponsor
- Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Not provided
Exclusion Criteria
1. Ccr < 30 mL/min 2. common use of anticoagulant, antiplatelet and the P glucoprotein repressor 3. perioperative amount of bleeding more than 600 ml 4. allergic to iodine contrast agent 5. Under 20 years old 6. inappropriate as a study subject
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VTE incidence on the 6th to 8th postoperative day.
- Secondary Outcome Measures
Name Time Method